Brief: Arcus Biosciences Q3 Revenue USD 20 Million Vs. IBES Estimate USD 24.6 Million
28/10/2025 20:05
Oct 28 (Reuters) - Arcus Biosciences Q3 operating expenses USD 168 million. Q3 operating income USD -142 million Q3 net income USD -135 million Q3 pretax profit USD -135 million
Recent news on Arcus Biosciences
See all newsU.S. STOCKS ON THE MOVE-Quest Diagnostics, Tractor Supply, Dutch Bros
U.S. STOCKS ON THE MOVE-CME, Lockheed Martin, Valero Energy
Arcus Biosciences tumbles on $250 mln share sale
Brief: Arcus Biosciences Announces Pricing Of $250 Million Public Offering Of Common Stock
Arcus Biosciences drops after starting stock offering